Macaques show low neutralizing antibody and cellular immune response to SARS-CoV-2
A new study published on the preprint server bioRxiv* in August 2020 presents a cynomolgus macaque model that develops symptomatic SARS-CoV-2 infection in a mild form, with low or no antibody responses, making it suitable to study human responses to vaccines and drugs targeting the virus.
No hay comentarios:
Publicar un comentario